In conclusion, our observations confirm that D-2-HG degradation is rather slow in comparison to its production in cells harbouring mutant IDH. This explains especially the high accumulation of D-2-HG in glioma tissue5, where there is no export into and distribution across other body fluids. Here, IDH1 is linked to glioma.